These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 28935026)

  • 1. Marginal structural model to evaluate the joint effect of socioeconomic exposures on the risk of developing end-stage renal disease in patients with type 1 diabetes: a longitudinal study based on data from the Swedish Childhood Diabetes Study Group.
    Pazzagli L; Möllsten A; Waernbaum I
    Ann Epidemiol; 2017 Aug; 27(8):479-484. PubMed ID: 28935026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of diabetic nephropathy, risk of end-stage renal disease and mortality in patients with type-1 diabetes.
    Bentata Y; Haddiya I; Latrech H; Serraj K; Abouqal R
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):392-402. PubMed ID: 23538374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Socio-economic factors influencing the development of end-stage renal disease in people with Type 1 diabetes - a longitudinal population study.
    Toppe C; Möllsten A; Schön S; Dahlquist G
    Diabet Med; 2017 May; 34(5):676-682. PubMed ID: 27862276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age at onset of childhood-onset type 1 diabetes and the development of end-stage renal disease: a nationwide population-based study.
    Svensson M; Nyström L; Schön S; Dahlquist G
    Diabetes Care; 2006 Mar; 29(3):538-42. PubMed ID: 16505502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study).
    Martínez-Castelao A; Gòrriz JL; Garcia-López F; López-Revuelta K; De Alvaro F; Cruzado JM;
    J Nephrol; 2004; 17(4):544-51. PubMed ID: 15372417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Has the incidence of end-stage renal disease increased in diabetic patients? A center-based longitudinal study over 10 years].
    Van Landeghem MA
    Med Klin (Munich); 2005 May; 100(5):241-5. PubMed ID: 15902377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added value of soluble tumor necrosis factor-α receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetes.
    Forsblom C; Moran J; Harjutsalo V; Loughman T; Wadén J; Tolonen N; Thorn L; Saraheimo M; Gordin D; Groop PH; Thomas MC;
    Diabetes Care; 2014 Aug; 37(8):2334-42. PubMed ID: 24879837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of continuity of care on the incidence of end-stage renal disease in patients with newly detected type 2 diabetic nephropathy: a retrospective cohort study.
    Jang YJ; Choy YS; Nam CM; Moon KT; Park EC
    BMC Nephrol; 2018 Jun; 19(1):127. PubMed ID: 29871604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes: a nationwide population-based cohort study.
    Möllsten A; Svensson M; Waernbaum I; Berhan Y; Schön S; Nyström L; Arnqvist HJ; Dahlquist G; ; ;
    Diabetes; 2010 Jul; 59(7):1803-8. PubMed ID: 20424230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal replacement therapy due to type 1 diabetes; time trends during 1995-2010--a Swedish population based register study.
    Toppe C; Möllsten A; Schön S; Jönsson A; Dahlquist G
    J Diabetes Complications; 2014; 28(2):152-5. PubMed ID: 24332762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time trends in the epidemiology of renal transplant patients with type 1 diabetes mellitus over the last four decades.
    Cao C; Hellermann JP; Weber M; Ambühl PM
    Nephrol Dial Transplant; 2006 Mar; 21(3):770-5. PubMed ID: 16401627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreasing Cumulative Incidence of End-Stage Renal Disease in Young Patients With Type 1 Diabetes in Sweden: A 38-Year Prospective Nationwide Study.
    Toppe C; Möllsten A; Waernbaum I; Schön S; Gudbjörnsdottir S; Landin-Olsson M; Dahlquist G;
    Diabetes Care; 2019 Jan; 42(1):27-31. PubMed ID: 30352897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of end-stage renal disease in patients with type 1 diabetes.
    Finne P; Reunanen A; Stenman S; Groop PH; Grönhagen-Riska C
    JAMA; 2005 Oct; 294(14):1782-7. PubMed ID: 16219881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Legacy effect in combined diabetic-renal multifactorial intervention in patients with advanced diabetic nephropathy.
    Kuzhively J; Tahsin B; Hart P; Fogelfeld L
    J Diabetes Complications; 2018 May; 32(5):474-479. PubMed ID: 29526625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes.
    Shultis WA; Weil EJ; Looker HC; Curtis JM; Shlossman M; Genco RJ; Knowler WC; Nelson RG
    Diabetes Care; 2007 Feb; 30(2):306-11. PubMed ID: 17259499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study.
    Keane WF; Brenner BM; de Zeeuw D; Grunfeld JP; McGill J; Mitch WE; Ribeiro AB; Shahinfar S; Simpson RL; Snapinn SM; Toto R;
    Kidney Int; 2003 Apr; 63(4):1499-507. PubMed ID: 12631367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes.
    Patente TA; Mohammedi K; Bellili-Muñoz N; Driss F; Sanchez M; Fumeron F; Roussel R; Hadjadj S; Corrêa-Giannella ML; Marre M; Velho G
    Free Radic Biol Med; 2015 Sep; 86():16-24. PubMed ID: 25862415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).
    Villar E; Chang SH; McDonald SP
    Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002.
    ; Stewart JH; McCredie MR; Williams SM
    Diabet Med; 2006 Dec; 23(12):1364-9. PubMed ID: 17116189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative Kidney Complication Risk by 50 Years of Type 1 Diabetes: The Effects of Sex, Age, and Calendar Year at Onset.
    Costacou T; Orchard TJ
    Diabetes Care; 2018 Mar; 41(3):426-433. PubMed ID: 28931542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.